Background {#Sec1}
==========

Increased left atrial (LA) size is associated with the occurrence of atrial fibrillation (AF) \[[@CR1]\]. Therefore, AF is frequently observed in patients with chronic mitral valve (MV) disease, which invariably induces LA remodeling \[[@CR2]--[@CR4]\]. On the other hand, reduction of LA size (reverse LA remodeling) can also occur after correction of MV pathology \[[@CR3], [@CR5]\]. It has been shown that the degree of reverse LA remodeling varies, particularly according to pre-operative cardiac rhythm. Moreover, pre-operative sinus rhythm is associated with larger degrees of reverse LA remodeling \[[@CR3]\]. In addition, this structural reversal can also induce reversal of electrophysiologic abnormalities that are predisposed to the occurrence of AF. Therefore, reversal of these changes by treatment, i.e., MV surgery, could potentially have important implications for the prevention of AF \[[@CR5], [@CR6]\]. Nevertheless AF can occur even after correction of MV pathology in patients who have undergone MV surgery \[[@CR7]--[@CR17]\]. However, the incidence and predictors of new onset permanent AF after MV surgery have not been clearly defined. Therefore, the aim of this study is to investigate the prevalence and predictors of the occurrence of new onset permanent AF in patients with MV diseases who have undergone MV surgery and sinus rhythm pre-operatively.

Methods {#Sec2}
=======

Study design and participants {#Sec3}
-----------------------------

A total of 1841 patients underwent MV surgery from June 1982 to February 2009. Among them, patients with pre-existing AF, concomitant MAZE procedure during surgery (*n* = 1189), patients with permanent pacemaker implantation (*n* = 20), and patients unknown pre-operative rhythm (*n* = 190) were excluded. The remaining 442 patients (mean age 46 ± 12, 191 men) comprised the study population (Fig. [1](#Fig1){ref-type="fig"}). We reviewed the medical records to define the etiology of MV pathology and reason for valve surgery in addition to pre- and post-operative transthoracic echocardiography (TTE) and electrocardiogram (ECG). ECG was taken pre- and post-operatively and at follow up once a year thereafter. New onset permanent AF was defined as the occurrence of AF post-operatively detected by post-operative ECG during the hospital stay and that persisted thereafter.Fig. 1Enrolled study subjects. Patients underwent surgery were sorted to the two groups - new onset permanent AF (AF, 81) vs. maintenance of sinus rhythm (NSR, 361)

Echocardiography {#Sec4}
----------------

TTE was performed by standard techniques with a 2.5-MHz transducer. Two-dimensional echocardiographic images were obtained in the standard parasternal long-axis and apical 2 and 4 chamber views. Left ventricular (LV) ejection fraction (EF) was assessed by the modified Quinones method. Mediolateral (ML) and superior/inferior (SI) dimensions of LA were measured from the apical 4 chamber view, and anteroposterior (AP) dimensions were measured from the parasternal long axis view at the end-systole. Maximal LA volume was calculated using the prolate ellipsoid model3 and indexed to the body surface area (LA volume index; LAVI). Measurement of LA volume was available in 200 of 442 patients at pre- and post-operative periods. In those patients, the LA volume change and the percentage of LA volume change were calculated \[[@CR18]\]. Assessment of valvuar heart diseases were based on the guidelines \[[@CR19]\].

Statistical analysis {#Sec5}
--------------------

Continuous variables are presented as means ± standard deviation (SD) and compared using Student's unpaired t test or Mann-Whitney's U test. Categorical variables are presented as numbers or percentages, and used the Chi-square test. To determine the variables associated with the occurrence of AF, logistic regression analysis was performed separately using clinical variables and echocardiographic findings. The predictive ability of the LAVI was determined by the area under the receiver-operating characteristic curves (ROC). Kaplan-Meier estimator was used for AF free survival curves. *P* value \< 0.05 was considered statistically significant.

Results {#Sec6}
=======

The enrolled patients were classified into the two groups according to the occurrence of permanent AF or maintained sinus rhythm after MV surgery (normal sinus rhythm \[NSR\] group vs. AF group). Post-operative new onset permanent AF occurred in 81 (18%) patients. Baseline characteristics of the study subjects are shown in Table [1](#Tab1){ref-type="table"}. The mean age at the time of surgery was similar in both groups. The majority of patients (81%) had rheumatic etiology and others (19%) had non-rheumatic etiology, such as infective endocarditis, MV prolapse, or chordae rupture. The proportion of rheumatic valve disease was significantly higher in patients with new onset permanent AF (*p* = 0.018). The median interval from the surgery to the occurrence of AF was 9.2 years (110.6 ± 78.9 months), and the mean follow-up duration was not significantly different in both groups (9.8 ± 5.9 years in the NSR vs. 9.4 ± 6.5 years in the AF, *p* = 0.566). The TTE parameters before and after surgery are listed in Table [2](#Tab2){ref-type="table"}. Pre- and post-operative LV EF were significantly lower in the AF group (63 ± 10% in the NSR vs. 59 ± 14% in the AF, *p* = 0.026 & 61 ± 10% in the NSR vs. 57 ± 14% in the AF, *p* = 0.006), although the LV EF of both groups were in normal range. Pre-operative LA AP dimension (51 ± 9 mm in the NSR vs. 53 ± 7 mm in the AF, *p* = 0.080) and LAVI (58 ± 25 ml/m^2^ in the NSR vs. 63 ± 23 ml/m^2^ in the AF, *p* = 0.399) were not significantly different in both groups. However, the degree of reduction of LAVI (21 ± 21 ml/m^2^ in the NSR vs. 11 ± 23 ml/m^2^ in the AF, *p* = 0.041) and percentage reduction of LAVI (28 ± 28% in the NSR vs. 10 ± 37% in the AF, *p* \< .001) were significantly smaller in the AF group (Fig. [2](#Fig2){ref-type="fig"}). Therefore, post-operative LA size was significantly larger in the AF group, shown as AP dimension (43 ± 6 mm in the NSR vs. 51 ± 8 mm in the AF, *p* \< .001) and LAVI (38 ± 13 ml/m^2^ in the NSR vs. 52 ± 16 ml/m^2^ in the AF, *p* \< .001). When the degree of reduction of LA dimension was compared according to the direction (AP, ML or SI), the change in SI direction was most prominent (Table [2](#Tab2){ref-type="table"}). Regarding the hemodynamic variables, the post-operative mean diastolic pressure gradient (MDPG) of the MV was significantly higher in patients with permanent AF group (3.5 ± 1.4 mmHg in the NSR vs. 3.9 ± 1.5 mmHg in the AF, *p* = 0.023). The grade of pre and post-operative tricuspid regurgitation (TR) were slightly higher in the AF group. Post-operative estimated pulmonary artery pressure (PAP) was also slightly higher in the AF group. In univariate analysis, rheumatic etiology (odds ratio \[OR\] = 2.474, 95% confidence interval \[CI\] = 1.143--5.355, *p* = 0.021), lower pre (OR = 0.971, 95% CI = 0.945--0.997, *p* = 0.028) and post-operative LV EF (OR = 0.970, 95% CI = 0.949--0.992, *p* = 0.007), higher post-operative MDPG across mitral prosthesis (OR = 1.212, 95% CI = 1.024--1.434, *p* = 0.025), lesser degree of reduction in LA size after surgery (OR = 0.790, 95% CI = 0.960--0.980, *p* \< 0.001), and large post-operative LA size (OR = 1.064, 95% CI = 1.045--1.083, *p* \< 0.001) were risk factors for the occurrence of AF. Presence of MS rather than pure MR (OR = 1.767, 95% CI = 0.981--3.182, *p* = 0.058) was associated with the occurrence of AF with borderline significance (Table [3](#Tab3){ref-type="table"}). Interestingly, none of the parameters reflecting pre-operative LA size was associated with post-operative AF. Pre and post-operative TR (OR = 1.864, 95% CI = 1.328--2.617, *p* \< 0.001 & OR = 2.641, 95% CI = 1.922--3.630, *p* \< 0.001) and postoperative higher PAP (OR = 1.067, 95% CI = 1.025--1.110, *p* = 0.001) were associated with the occurrence of AF. In multivariate analysis, post-operative LAVI was an independent predictor for the occurrence of AF (Table [4](#Tab4){ref-type="table"}). The predictive ability of the LAVI was determined by the area under the curve of the receiver operating curve and post-operative LAVI \> 39 ml/m^2^ (cut-off value) was associated with new onset permanent AF (sensitivity: 79%, AUC: 0.762, SE: 0.051, *p* \< 0.001). The AF-free survival curves of patients with post-op LAVI \< 39 ml/m2 or ≥39 ml/m2 are shown in Fig. [3](#Fig3){ref-type="fig"} (*p* = 0.06).Table 1Baseline characteristics of the patientsVariablesNSR (*n =* 361)AF (*n =* 81)*p*Age at surgery (years)41 ± 1341 ± 110.782Male gender151 (42%)39 (49%)0.264Body surface area (m^2^)1.65 ± 0.161.64 ± 0.160.967Etiology0.018 Rheumatic etiology284 (79%)73 (90%) Non-rheumatic valvular disease77 (21%)8 (10%)Diagnosis0.065 Pure mitral regurgitation205 (57%)37 (46%) Presence of mitral stenosis156 (43%)44 (54%)Combined with other valve180 (58%)44 (70%)0.091Type of surgery0.478 Mitral valve replacement348 (96.4%)79 (97.5%)  Bioprosthesis7 (2.0%)2 (2.5%)  Mechanical341 (98.0%)77 (97.5%) Mitral valve repair13 (3.6%)2 (2.5%)Annular size28.4 ± 2.129.0 ± 2.60.070Preoperative heart rate (bpm)76 ± 1975 ± 150.762Preoperative blood pressure (mmHg) Systolic blood pressure121 ± 17123 ± 160.825  Diastolic blood pressure75 ± 1374 ± 100.623Postoperative HR73 ± 1872 ± 140.854Postoperative blood pressureSystolic blood pressure119 ± 15120 ± 150.718Diastolic blood pressure73 ± 1174 ± 110.777Table 2Echocardiographic parameters before and after surgeryNSR (*n =* 361)AF (*n =* 81)*p*Before surgery LV end diastolic dimension (mm)56.6 ± 10.855.0 ± 10.90.375 LV end systolic dimension (mm)38.4 ± 9.238.7 ± 9.90.863 LV ejection fraction (%)62.7 ± 10.058.9 ± 14.10.026 LA antero-posterior dimension (AP) (mm)50.7 ± 8.753.1 ± 6.90.080 LA medio-lateral dimension (ML) (mm)56.2 ± 10.658.6 ± 9.90.339 LA supero-inferior dimension (SI) (mm)62.4 ± 9.760.4 ± 9.10.372 LA volume index (ml/m^2^)^a^58.4 ± 24.962.9 ± 22.80.399 TR grade0.4 ± 0.81.2 ± 1.10.005 Estimated PAP39.2 ± 17.544.5 ± 18.40.252After surgery LV end diastolic dimension (mm)48.9 ± 5.350.1 ± 8.90.126 LV end systolic dimension (mm)33.8 ± 5.835.9 ± 10.80.015 LV ejection fraction (%)60.9 ± 9.557.2 ± 13.80.006 LA AP dimension (mm)42.9 ± 6.050.7 ± 8.1\< .001 LA ML dimension (mm)50.3 ± 6.856.3 ± 7.5\< .001 LA SI dimension (mm)57.3 ± 27.561.8 ± 8.20.172 LA AP change (mm)7.7 ± 8.44.1 ± 7.90.011 LA ML change (mm)6.7 ± 10.43.4 ± 10.10.197 LA SI change (mm)7.4 ± 9.01.3 ± 8.30.005 LA volume index (ml/m^2^)37.9 ± 12.652.1 ± 15.6\< .001 LA volume change (ml/m^2^)20.5 ± 21.310.8 ± 23.40.041 LA volume change %28.1 ± 27.99.5 ± 36.8\< .001 MDPG of the MV (mmHg)3.5 ± 1.43.9 ± 1.50.023 Residual mitral regurgitation0.337  No352 (97.5%)77 (95.1%)  Trivial8 (2.2%)3 (3.7%)  More than grade I1 (0.3%)1 (1.2%) TR grade0.3 ± 0.61.0 ± 1.0\< 0.001 Estimated PAP26.4 ± 6.629.8 ± 7.10.001 TAP or TVR33 (7.5%)6 (1.4%)0.828^a^LA volume index was available only in 200 patients (176 of NSR, 24 of AF); *NSR* normal sinus rhythm, *AF* atrial fibrillation, *LV* left ventricular, *LA* left atrial, *MDPG* mean diastolic pressure gradient, *TR* tricuspid regurgitation, *PAP* pulmonary artery pressure, *TAP* tricuspid valve repair with an annuloplasty ring, *TVR* tricuspid valve replacementFig. 2Degree of left atrial reverse remodeling. LAVI, left atrial volume index; Δ LAVI, change of LAVI; % Δ LAVI, percent change of LAVI, NSR, maintenance of normal sinus rhythm; AF, new onset permanent AFTable 3Factors determining the occurrence of atrial fibrillation after surgery (univariate analysis)VariablesOdds ratio95% confidence interval*p*Rheumatic VHD2.4741.143--5.3550.021Presence of MS1.7670.981--3.1820.058Preoperative LV EF0.9710.949--0.9920.028Postoperative LV EF0.9700.949--0.9920.007Δ LAVI0.9600.940--0.9900.007% Δ LAVI0.7900.960--0.980\< .001Postoperative LAVI1.0641.045--1.083\< .001Postoperative MDPG1.2121.024--1.4340.025Preoperative TR1.8641.328--2.617\< 0.001Postoperative TR2.6411.922--3.630\< 0.001Postoperative PAP1.0671.025--1.1100.001*VHD* valvular heart disease, *MS* mitral stenosis, *LV* Left ventricular, *EF* ejection fraction, *Δ* change, *LAVI* left atrial volume index, *MDPG* mean diastolic pressure gradient, *TR* tricuspid valve regurgitation, *PAP* pulmonary artery pressrueTable 4Factors determining the occurrence of atrial fibrillation after surgery (multivariate analysis)VariablesOdds ratio95% confidence interval*p*Rheumatic VHD4.6830.716--30.4600.107Presence of MS3.5340.884--14.1250.074Preoperative LV EF0.9970.953--1.0430.815Postoperative LV EF1.0040.957--1.0540.863% Δ LAVI0.9930.976--1.0100.409Postoperative LAVI1.0981.047--1.153\< .001Postoperative MDPG of MV0.9020.557--1.4590.673Preoperative TR0.6860.181--2.5960.579Postoperative TR2.2740.896--5.7730.084Postoperative PAP0.9300.788--1.0970.389*VHD* valvular heart disease, *MS* mitral stenosis, *LV* Left ventricular, *EF* ejection fraction, *Δ* change, *LAVI* left atrial volume index, *MDPG* mean diastolic pressure gradient, *MV* mitral valve, *TR* tricuspid valve regurgitation, *PAP* pulmonary artery pressrueFig. 3AF free survival curves

Discussion {#Sec7}
==========

In the present study, the prevalence and predictors of new onset permanent AF after MV surgery were investigated. The results showed that new onset permanent AF is not uncommon, occurring in about 20% of patients even after successful MV surgery and pre-operative sinus rhythm. Although several parameters, such as rheumatic etiology of MV, presence of mitral stenosis (MS), lower LV EF, higher post-operative mean diastolic pressure gradient across mitral prosthesis, and lesser degree of reverse LA remodeling after surgery, were shown to be associated with the occurrence of post-operative AF, post-operative LAVI was found to be an independent predictor for the occurrence of AF in multivariate analysis. Interestingly, none of the parameters reflecting pre-operative LA size was associated with post-operative AF. These findings underscore the importance of post-operative echocardiographic assessment before dismissal of the evaluation of LV function and LA size even in patients who have undergone successful MV surgery and pre-operative sinus rhythm.

Factors associated with new onset permanent AF {#Sec8}
----------------------------------------------

### Reverse LA remodeling and post-operative AF {#Sec9}

The degree of LA reverse remodeling was different in the two groups and showed that the reduction of LAVI and decrease in percentage of LAVI were smaller in the post-op AF group. Accordingly, post-operative LA size was significantly larger in the post-op AF group. In a previous study, post-operative LAVI ≥60 ml/m^2^ was shown to be associated with adverse clinical outcomes in patients with organic mitral regurgitation (MR) \[[@CR19]\]. In our study, 9 (47%) of 19 patients who had post-operative LAVI ≥60 ml/m^2^ developed new onset permanent AF, whereas 15 (8%) of 181 patients who had post-operative LAVI \< 60 ml/m2 had new onset AF (*p* \< 0.001). These findings are consistent with previous research \[[@CR20]\]. However, in our study, post-operative LAVI ≥39 ml/m^2^ was selected as a cut-off value for new onset AF. It had a sensitivity of 79% as well as the largest AUC (0.762). The smaller cut-off value of LAVI in our study was probably due to the inclusion of the patients with MS in our study. Regarding the direction of LA reverse remodeling, the change in SI dimension was the most prominent when compared with that of the AP and ML dimensions. Therefore, assessing the change in LA size only in the AP dimension may not accurately reflect the change in LA size. Thus, the degree of LA reverse remodeling could be underestimated.

### Impact of LV systolic function on post-operative AF {#Sec10}

In our study, lower pre- and post-operative LV EF was also associated with new onset AF. Despite similar pre-operative LAVI, lesser degrees of reduction in LAVI and decreases in percentage of LAVI occurred in patients with LV EF \< 60%. LV systolic dysfunction usually accompanies LV diastolic dysfunction and elevated LV filling pressures. Despite similar LA size, the presence of LV systolic dysfunction and concomitant LV diastolic dysfunction with elevated LV filling pressure might interfere with LA reverse remodeling.

### Pre-operative etiology of MV pathology {#Sec11}

New onset permanent AF occurred more frequently in patients with rheumatic etiology and presence of MS rather than pure MR. Because LA kinetic energy is different in MS and MR, a long-standing pressure overload of the LA in MS might be associated with higher LA kinetic energy than volume overload in MR. Therefore, increased LA work in MS may result in further LA fatigue and failure over time, which may disturb LA reverse remodeling \[[@CR2], [@CR21]\].

Role of post-operative echocardiography before dismissal {#Sec12}
--------------------------------------------------------

Although successful intervention was performed on diseased MV, AF can occur in patients with post-operative LAVI ≥39 ml/m^2^ according to the results from our study. Therefore, it is imperative to not only focus on the successful results of valve surgery but also perform post-operative echocardiography to evaluate post-operative LAVI to predict the occurrence of AF.

Echocardiography has a different role in the evaluation of valvular heart disease (VHD) at different stages before and after surgery. Pre-operative TTE should provide an accurate diagnosis to determine the possible cause of valvular diseases \[[@CR22], [@CR23]\]. In addition, quantitative echocardiographic evaluation of LV size and function is a key factor in clinical decision making in adults with VHD \[[@CR24]--[@CR27]\]. Other key echocardiographic data includes LV diastolic function, LA enlargement, and the presence of intra-cardiac thrombus, pulmonary artery pressures, and so on \[[@CR28]\]. Despite the important information obtained from pre-operative echocardiography, none of the pre-operative echocardiographic parameters provides predictive information regarding post-operative permanent AF in this study. Intra-operatively, transesophageal echocardiography (TEE) provides a roadmap for the surgeons regarding the location and severity of MV pathologic lesions, enhancing the ability to detect unexpected associated lesions. In addition, intra-operative TEE is used to confirm results of surgical procedures on the MV, which can result in improved surgical outcomes \[[@CR28], [@CR29]\]. Therefore, the American College of Cardiology and the American Heart Association have established guidelines for the management of patients with VHD, which state that the use of intra-operative TEE in MV repair is a class I indication \[[@CR30]\].

Although the importance of pre-operative and intra-operative echocardiographic evaluations of MV disease has been well recognized, the role of post-operative pre-discharge TTE has been overlooked in patients undergoing MV surgery. Unlike pre-operative echocardiographic parameters, post-operative LAVI measured before dismissal was able to predict the occurrence of post-operative permanent AF in patients undergoing MV surgery. Based on these results, the importance of post-operative echocardiographic assessment is emphasized not only for assessing the results of MV surgery but also for evaluating cardiac chamber size and function, particularly LA volume.

Limitations {#Sec13}
-----------

The current study has several limitations. First, it was a retrospective study, so the data collection was done by reviewing medical charts and recorded echocardiographic data. Therefore, the measurement of LAVI was available in only 200 of 442 patients, and only echocardiographic report was available in the remainder. And, the majority of the study patients had undergone MVR rather than MV repair. Anticoagulation is one of the most important treatments for AF. However, all patients should have life-long anticoagulation therapy for the implanted valve, except for MV reconstructions and bioprosthetic valve implantation. Therefore, our results cannot apply to patients who have undergone MV repair.

Conclusions {#Sec14}
===========

Newly developed postoperative permanent AF is not uncommon, occurring in 18% of patients who have undergone successful MV surgery despite pre-operative sinus rhythm. Rheumatic etiology, the presence of MS, lower LV EF, lesser degree of LA reverse remodeling, and larger post-operative LAVI were associated with new onset permanent AF. Post-operative LAVI \> 39 ml/m2 was an independent predictor for the occurrence of AF.
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